Right Ventricle Morphology and Hemodynamics in BrS

NCT03524079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-05-18

No results posted yet for this study

Summary

The study purpose is to evaluate the morphological, functional and electrophysiological characteristics of the right ventricle before and after ajmaline in patients diagnosed with Brugada syndrome as well as to correlate CMR findings and substrate size.

Conditions

  • Brugada Syndrome

Interventions

DRUG

Ajmaline 17-(Chloroacetate) Monohydrochloride

Ajmaline 17-(Chloroacetate) Monohydrochloride(1mg/kg in 5 minutes)

Sponsors & Collaborators

  • IRCCS Policlinico S. Donato

    lead OTHER

Principal Investigators

  • Carlo Pappone, MD · IRCCS San Donato University Hospital Policlinico San Donato, Milan, Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-19
Primary Completion
2019-11-08
Completion
2019-11-09

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03524079 on ClinicalTrials.gov